FDA clears Nurix Therapeutics, Inc.'s GS-6791 for inflammatory disorders; Nurix earns $5M milestone from Gilead. Click for my ...

Fixstars Corporation (TSE Prime: 3687, US Headquarters: Irvine, USA), a company dedicated to advancing AI technologies through world-class performance engineering, today announced its participation as ...

Horizons Across Disease, Demography and Technology," in Washington, D.C., bringing together industry, academic, and non-profit leaders from around the world to ...

Story April 10 - Pfizer: The Big Pharma sold its five-building ... The French biotech made five employees redundant after losing its partnership with Servier. OPM’s CEO and chief scientific ...

The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for autoimmune diseases.

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $125.5 billion, the company ...

Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The ...

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...